Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Apr 24:12:828.
doi: 10.3332/ecancer.2018.828. eCollection 2018.

The current state of prostate cancer treatment in Trinidad and Tobago

Affiliations
Review

The current state of prostate cancer treatment in Trinidad and Tobago

Satyendra Persaud et al. Ecancermedicalscience. .

Abstract

Prostate cancer mortality in the Caribbean region is among the highest in the world and prostate cancer is the most common cancer in Trinidad and Tobago. There is a two-tiered healthcare system in Trinidad and Tobago, and prostate cancer related issues account for a significant percentage of urologists' workload. Delivery of care is sometimes constrained by limited financial resources. Prostate-specific antigen testing is widely available but there is no national guideline. Treatment options available include active surveillance, radical prostatectomy, external beam radiotherapy and brachytherapy. Patients have access to androgen deprivation, chemotherapy and palliative care for the management of advanced disease. Generally, the infrastructure for treatment in Trinidad and Tobago is satisfactory but would benefit from further investments in technology and human resources.

Keywords: Caribbean; Trinidad and Tobago; prostate cancer.

PubMed Disclaimer

References

    1. Trinidad and Tobago. Housing and population census. 2000. [02/01/17]. [ http://cso.gov.tt/census/2000-census-data]
    1. Center M, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61:1079–1092. doi: 10.1016/j.eururo.2012.02.054. - DOI - PubMed
    1. Mungrue K, Moonan S, Mohammed M, et al. Prostate cancer survival in Trinidad: is PSA a prognostic factor? Can Urol Assoc J. 2012;6:249–255. doi: 10.5489/cuaj.125. - DOI - PMC - PubMed
    1. Hosein I, Sukhraj R, Goetz L, et al. A clinicopathological profile of prostate cancer in trinidad and trobago. Adv Urol. 2016. [01/03/17]. - DOI - PMC - PubMed
    1. McDonald M, Parsons J. The case for tailored prostate cancer screening: an NCCN perspective. J Natl Compr Canc Netw. 2015;13:1576–1583. doi: 10.6004/jnccn.2015.0183. - DOI - PubMed

LinkOut - more resources